glp 1 types of drugs Indications for GLP-1/GIP RA Summary Sheet and Beyond! GLP-1 Drug Comparison in Diabetes

LEADER (Liraglutide Effect and Action in Diabetes: Evaluation of Cardiovascular Outcomes Results) trial revealed that patients who received liraglutide had a lower risk of the primary composite outcome as listed above, cardiovascular death, death from any cause, and microvascular events than the placebo group [10]

However, this effect might be independent of changes in visceral fat accumulation since previous studies have demonstrated that the hepatic glucose production is decreased in healthy individuals following acute administration of both native GLP-1 ( de novo lipogenesis and reduces levels of lipolysis-induced FFA and triglyceride-derived toxic metabolites ( Insulinotropic effect As alluded above, patients with NAFLD, in whole its spectrum including cirrhotic individuals, show a reduced incretin effect

Now, let's get to the news: Blue Cross Blue Shield of Massachusetts , the state's largest commercial health insurer, is rolling back its coverage of GLP-1 drugs like Ozempic and Wegovy for weight loss

To view a copy of this licence, visit About this article Cite this article Cedirian, S., Donati, M., Rapparini, L

Prescriptions dropped 94% between 2012 and 2023 (IQVIA prescription data)